Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
The status of drug discovery and development for Alzheimer's disease
Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs
Adoption of complex disease modeling brings new optimism and hope to drug discovery
White paper: Advancing drug discovery for neurodegenerative diseases
Research highlights: iPSCs for gene therapy development